We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A structured patient empowerment programme for primary immunodeficiency significantly improves general and health-related quality of life.
- Authors
FASSHAUER, MARIA; SCHUERMANN, GESINE; GEBERT, NORBERT; BERNUTH, HORST VON; GOLDACKER, SIGUNE; KRUEGER, RENATE; MANZEY, PETRA; NOTHEIS, GUNDULA; RITTERBUSCH, HENRIKE; SCHAUER, UWE; SCHULZE, ILKA; UMLAUF, VOLKER; WIDMANN, STEFFI; BAUMANN, ULRICH
- Abstract
Introduction: Primary immunodeficiencies (PIDs) are a heterogeneous group of rare diseases characterized by increased susceptibility to infections and a reduced quality of life (QoL). The influence of a patient empowerment programme for PID (PID-PEP) on general and health-related QoL was assessed in the present study. Material and methods: PID-PEP is provided by a multidisciplinary team for patients with PID and immunoglobulin G (IgG) replacement therapy during a weekend course to improve patient self-management regarding chronic disease and long-term therapy. Twenty-six adult patients with PID undergoing PID-PEP were recruited. Short Form-36 (SF-36) and the Life Quality Index (LQI) were assessed as generic and disease-specific QoL instruments before as well as 6 months after the programme. Results: Median visual analogue scale (VAS) values of present health status significantly increased from 68 at baseline to 76 after PID-PEP (p = 0.002). Furthermore, the SF-36 mental component summary (MCS) significantly improved from 36 to 43 following the programme (p = 0.042). Of the eight SF-36 dimensions, vitality (VT) significantly improved (p = 0.025). Median LQI index significantly increased from 77 at baseline to 86 after PID-PEP (p = 0.008). Furthermore, the LQI domains treatment interference (I) and therapy-related problems (II) significantly improved. Conclusions: Our PID-PEP significantly improved general and health-related QoL. It needs to be evaluated in future studies whether the beneficial effects of PID-PEP are sustained over longer periods of time and whether repeated PID-PEP sessions further improve QoL outcome.
- Subjects
PATIENT participation; PRIMARY immunodeficiency diseases; PELVIC inflammatory disease; QUALITY of life; VISUAL analog scale; IMMUNOGLOBULIN G
- Publication
Central European Journal of Immunology, 2021, Vol 46, Issue 2, p244
- ISSN
1426-3912
- Publication type
Article
- DOI
10.5114/ceji.2021.107088